Announcements Trials
Browse Landscape

Phase

Phase NA 51Phase 4 32Phase 3 32Phase 2 25Phase 1/2 8Phase 1 8Phase EARLY_PHASE1 2Phase 2/3 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Pleural Effusion, Malignant 1Pancreatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 59Cyclophosphamide 44pembrolizumab 34Radiotherapy 30fludarabine 27Nivolumab 26Biopsy 26Metformin 22Fluorodeoxyglucose F18 22Specimen Handling 20Bevacizumab 20Temozolomide 17Radiosurgery 17Cisplatin 16Carboplatin 14Fluorouracil 13Dexamethasone 13Paclitaxel 12Gemcitabine 12Etoposide 12gallium 68 PSMA-11 11durvalumab 11X-Rays 11Surgical Procedures, Operative 11Radiation 11Positron Emission Tomography Computed Tomography 11Letrozole 11Irinotecan 11Ipilimumab 11Surveys and Questionnaires 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER × Sodium Chloride × Clear all
NCT04048278 2025-03-03

Lidocaine Infusion in Pancreatic Cancer

University of Illinois at Chicago

Phase EARLY_PHASE1 Recruiting
46 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT05565014 2022-10-04

Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion

Hubei Cancer Hospital

Phase EARLY_PHASE1 Unknown
90 enrolled
Thoracic

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡